Physician

Anwar Khurshid, MD

According to 2025 Medicare claims, Anwar Khurshid, MD (NPI: 1922000488) practices medical oncology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1033386578; TIN: 752131429) and primary practice location at 76012-2510. Khurshid is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Khurshid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 424 traditional Medicare patients, billed 61,588 HCPCS/CPT codes, and received $1,256,810 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,289 prescription claims across 212 beneficiaries totaling $1,621,589 in drug costs, led by Calquence (Acalabrutinib Maleate). 2022 DME data shows 12 claims. Open Payments data shows 7 records totaling $172. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $229,134 to $1,256,810. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,076,086 to $1,621,589. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $6,002 to $996.